Literature DB >> 16399356

Estrogen sulfatase.

Masao Iwamori1.   

Abstract

Estrogen sulfatase is a microsomal enzyme and is ubiquitously distributed in several mammalian tissues, among which the liver, placenta, and endocrine tissues exhibit relatively high activity. Because the major circulating precursors of estrogen are estrone 3-sulfate and dehydroepiandrosterone 3-sulfate, estrogen sulfatase plays an important role not only in their incorporation and metabolism, but also in the controls of estrogen activity by regulating the binding potential of estrogen as to its receptor through sulfoconjugation and desulfation reactions. Accordingly, an increase in sulfoconjugation through transfection of the sulfotransferase gene or inhibition of estrogen sulfatase by specific inhibitors has been successfully applied to abolish the estrogen activity in estrogen-dependent breast cancer- and uterine endometrial adenocarcinoma-derived cells. Inhibitors of estrogen sulfatase are expected to be developed as new drugs for estrogen-dependent cancer therapy, particularly in postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16399356     DOI: 10.1016/S0076-6879(05)00017-0

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  6 in total

1.  The human estrogen sulfotransferase: a half-site reactive enzyme.

Authors:  Meihao Sun; Thomas S Leyh
Journal:  Biochemistry       Date:  2010-06-15       Impact factor: 3.162

2.  SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.

Authors:  Tanda M Dudenkov; James N Ingle; Aman U Buzdar; Mark E Robson; Michiaki Kubo; Irada Ibrahim-Zada; Anthony Batzler; Gregory D Jenkins; Tracy L Pietrzak; Erin E Carlson; Poulami Barman; Matthew P Goetz; Donald W Northfelt; Alvaro Moreno-Aspita; Clark V Williard; Krishna R Kalari; Yusuke Nakamura; Liewei Wang; Richard M Weinshilboum
Journal:  Breast Cancer Res Treat       Date:  2017-04-20       Impact factor: 4.872

3.  Redox regulation of human estrogen sulfotransferase (hSULT1E1).

Authors:  Smarajit Maiti; Jimei Zhang; Guangping Chen
Journal:  Biochem Pharmacol       Date:  2006-12-28       Impact factor: 5.858

4.  24-hydroxycholesterol sulfation by human cytosolic sulfotransferases: formation of monosulfates and disulfates, molecular modeling, sulfatase sensitivity, and inhibition of liver x receptor activation.

Authors:  Ian T Cook; Zofia Duniec-Dmuchowski; Thomas A Kocarek; Melissa Runge-Morris; Charles N Falany
Journal:  Drug Metab Dispos       Date:  2009-07-09       Impact factor: 3.922

Review 5.  Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A.

Authors:  J G Hengstler; H Foth; T Gebel; P-J Kramer; W Lilienblum; H Schweinfurth; W Völkel; K-M Wollin; U Gundert-Remy
Journal:  Crit Rev Toxicol       Date:  2011-04       Impact factor: 5.635

6.  Does rapid metabolism ensure negligible risk from bisphenol A?

Authors:  Gary Ginsberg; Deborah C Rice
Journal:  Environ Health Perspect       Date:  2009-07-14       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.